Free Trial
NYSE:ABT

Abbott Laboratories (ABT) Stock Price, News & Analysis

$101.95
-2.00 (-1.92%)
(As of 05/28/2024 ET)
Today's Range
$101.56
$103.59
50-Day Range
$101.95
$113.66
52-Week Range
$89.67
$121.64
Volume
4.72 million shs
Average Volume
5.63 million shs
Market Capitalization
$177.36 billion
P/E Ratio
31.76
Dividend Yield
2.16%
Price Target
$120.60

Abbott Laboratories MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
18.3% Upside
$120.60 Price Target
Short Interest
Healthy
0.85% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.10
Upright™ Environmental Score
News Sentiment
0.51mentions of Abbott Laboratories in the last 14 days
Based on 20 Articles This Week
Insider Trading
Selling Shares
$3.65 M Sold Last Quarter
Proj. Earnings Growth
10.82%
From $4.62 to $5.12 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.95 out of 5 stars

Medical Sector

20th out of 931 stocks

Pharmaceutical Preparations Industry

6th out of 426 stocks

ABT stock logo

About Abbott Laboratories Stock (NYSE:ABT)

Abbott Laboratories is a global healthcare company specializing in developing, manufacturing and marketing a wide range of healthcare products. The company has its headquarters in Abbott Park, Illinois and operates in more than 160 countries worldwide.

The company was founded in 1888 by Dr. Wallace C. Abbott, and it has since grown to become one of the world's largest and most respected healthcare companies. Abbott Laboratories has a diverse portfolio of products, including medical devices, diagnostic tests, nutritional products, and branded generic pharmaceuticals. The company is committed to developing innovative products that improve the quality of life for people worldwide.

Robert B. Ford is the current President and CEO of the company. He was appointed to this position in 2020 after serving as the company's Chief Operating Officer. He has been with Abbott Laboratories since 1996 and has held various leadership positions.

Abbott Laboratories has delivered strong financial performance, declining as investors seek growth. The company's net earnings have been increasing steadily. Abbott Laboratories has a solid balance sheet with a low debt-to-equity ratio. The company has consistently delivered strong cash flow, allowing it to invest in research and development and return value to shareholders. Abbott Laboratories has a higher price-to-earnings ratio than the industry average, and the company's price-to-book ratio is also higher than the industry average. These metrics suggest that the market has a positive outlook on Abbott Laboratories and is willing to pay a premium for the company's shares. Over the past year, Abbott Laboratories' stock has declined as consumers seek to see what the company will do post-pandemic. The company's shares have experienced some volatility, but overall, they have outperformed the broader market. 

Abbott Laboratories operates in the healthcare industry, which is highly regulated and complex. The industry is characterized by rapidly evolving technology, changing regulatory requirements, and shifting consumer preferences. Abbott Laboratories competes with other large healthcare companies such as Johnson & Johnson.

Abbott Laboratories' robust product pipeline is expected to drive growth in the coming years. The company is focused on developing innovative products that address unmet medical needs and improve patient outcomes. In addition to its core businesses, Abbott Laboratories is expanding into new markets and investing in digital health technologies.

Like any company, Abbott Laboratories faces a range of risks and challenges. One of the most significant risks facing the company is regulatory uncertainty. Changes in regulatory requirements could impact the company's ability to bring products to market and could also increase the cost of doing business. Another risk facing the company is the threat of competitive pressures. The healthcare industry is highly competitive, and Abbott Laboratories faces competition from established companies and new entrants. Changes in consumer preferences could also impact the company's performance, particularly in the nutritional products segment.

Additionally, Abbott Laboratories is exposed to geopolitical risks, such as changes in trade policies or political instability in key markets. The company's international operations also expose it to currency fluctuations, which could impact its financial performance.

ABT Stock Price History

ABT Stock News Headlines

Boston Scientific Bucks the Medtech Slow Down and Raises Outlook (ABT)
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.
Greg Abbott Faces New Republican Test
Abbott Laboratories (NYSE:ABT) Price Target Cut to $119.00
RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT)
See More Headlines
Receive ABT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abbott Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/15 Dividend
4/12/2024
Last Earnings
4/17/2024
Dividend Payable
5/15/2024
Today
5/28/2024
Next Earnings (Estimated)
7/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Health Care Equipment
CUSIP
00282410
CIK
1800
Employees
114,000
Year Founded
1888

Price Target and Rating

Average Stock Price Target
$120.60
High Stock Price Target
$140.00
Low Stock Price Target
$107.00
Potential Upside/Downside
+18.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
9 Analysts

Profitability

Net Income
$5.72 billion
Pretax Margin
16.21%

Debt

Sales & Book Value

Annual Sales
$40.11 billion
Cash Flow
$6.24 per share
Book Value
$22.36 per share

Miscellaneous

Outstanding Shares
1,739,630,000
Free Float
1,731,458,000
Market Cap
$177.36 billion
Optionable
Optionable
Beta
0.76

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

ABT Stock Analysis - Frequently Asked Questions

Should I buy or sell Abbott Laboratories stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abbott Laboratories in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ABT shares.
View ABT analyst ratings
or view top-rated stocks.

What is Abbott Laboratories' stock price target for 2024?

9 Wall Street research analysts have issued 1-year price objectives for Abbott Laboratories' stock. Their ABT share price targets range from $107.00 to $140.00. On average, they anticipate the company's stock price to reach $120.60 in the next twelve months. This suggests a possible upside of 18.3% from the stock's current price.
View analysts price targets for ABT
or view top-rated stocks among Wall Street analysts.

How have ABT shares performed in 2024?

Abbott Laboratories' stock was trading at $110.07 at the beginning of the year. Since then, ABT stock has decreased by 7.4% and is now trading at $101.95.
View the best growth stocks for 2024 here
.

Are investors shorting Abbott Laboratories?

Abbott Laboratories saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 14,480,000 shares, an increase of 11.9% from the April 15th total of 12,940,000 shares. Based on an average daily volume of 5,600,000 shares, the short-interest ratio is presently 2.6 days. Currently, 0.8% of the company's stock are short sold.
View Abbott Laboratories' Short Interest
.

When is Abbott Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 18th 2024.
View our ABT earnings forecast
.

How were Abbott Laboratories' earnings last quarter?

Abbott Laboratories (NYSE:ABT) posted its quarterly earnings data on Wednesday, April, 17th. The healthcare product maker reported $0.98 earnings per share for the quarter, beating analysts' consensus estimates of $0.96 by $0.02. The healthcare product maker had revenue of $9.96 billion for the quarter, compared to analysts' expectations of $9.88 billion. Abbott Laboratories had a trailing twelve-month return on equity of 20.18% and a net margin of 13.96%. The company's revenue was up 2.2% on a year-over-year basis. During the same period last year, the company earned $1.03 EPS.
Read the conference call transcript
.

How often does Abbott Laboratories pay dividends? What is the dividend yield for Abbott Laboratories?

Abbott Laboratories announced a quarterly dividend on Friday, February 16th. Stockholders of record on Monday, April 15th will be paid a dividend of $0.55 per share on Wednesday, May 15th. This represents a $2.20 annualized dividend and a dividend yield of 2.16%. The ex-dividend date is Friday, April 12th.
Read our dividend analysis for ABT
.

Is Abbott Laboratories a good dividend stock?

Abbott Laboratories (NYSE:ABT) pays an annual dividend of $2.20 per share and currently has a dividend yield of 2.12%. The company has been increasing its dividend for 53 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 68.54%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ABT will have a dividend payout ratio of 42.97% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ABT.

What guidance has Abbott Laboratories issued on next quarter's earnings?

Abbott Laboratories issued an update on its FY24 earnings guidance on Wednesday, April, 17th. The company provided earnings per share (EPS) guidance of $4.55-4.70 for the period, compared to the consensus estimate of $4.62.

What is Robert Ford's approval rating as Abbott Laboratories' CEO?

183 employees have rated Abbott Laboratories Chief Executive Officer Robert Ford on Glassdoor.com. Robert Ford has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Abbott Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Abbott Laboratories investors own include AbbVie (ABBV), Johnson & Johnson (JNJ), NVIDIA (NVDA), AT&T (T), Pfizer (PFE), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), Home Depot (HD) and Verizon Communications (VZ).

Who are Abbott Laboratories' major shareholders?

Abbott Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.50%), Capital Research Global Investors (4.83%), Capital International Investors (4.03%), Bank of New York Mellon Corp (0.85%), Flossbach Von Storch AG (0.49%) and Janus Henderson Group PLC (0.46%). Insiders that own company stock include Andrea F Wainer, Andrew H Lane, Daniel Gesua Sive Salvadori, Daniel J Starks, Fernando Mateus, John A Jr Mccoy, John F Ginascol, Joseph J Manning, Jr Robert E Funck, Julie L Tyler, Lisa D Earnhardt, Louis H Morrone, Mary K Moreland, Michael D Dale, Michael J Pederson, Nancy Mckinstry, Philip P Boudreau, Randel William Woodgrift, Robert B Ford and Sammy Karam.
View institutional ownership trends
.

How do I buy shares of Abbott Laboratories?

Shares of ABT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Abbott Laboratories have any subsidiaries?
The following companies are subsidiares of Abbott Laboratories: 3A Nutrition (Vietnam) Company Limited, ABON Biopharm (Hangzhou) Co. Ltd., AGA Medical Belgium, AGA Medical Corporation, AGA Medical Holdings Inc., ALR Holdings, AML Medical LLC, APK Advanced Medical Technologies LLC, ATS Bermuda Holdings Limited, ATS Laboratories Inc., Abbott, Abbott (Jiaxing) Nutrition Co. Ltd., Abbott (UK) Finance Limited, Abbott (UK) Holdings Limited, Abbott AG, Abbott Asia Holdings Limited, Abbott Asia Investments Limited, Abbott Australasia Holdings Limited, Abbott Australasia Pty Ltd, Abbott B.V., Abbott Bahamas Overseas Businesses Corporation, Abbott Belgian Investments, Abbott Bermuda Holding Ltd., Abbott Biologicals B.V., Abbott Biologicals LLC, Abbott Bulgaria Luxembourg S.à r.l., Abbott Capital India Limited, Abbott Cardiovascular Inc., Abbott Cardiovascular Systems Inc., Abbott Delaware LLC, Abbott Diabetes Care Inc., Abbott Diabetes Care Limited, Abbott Diabetes Care Sales Corporation, Abbott Diagnostics GmbH, Abbott Diagnostics International Ltd., Abbott Diagnostics Technologies AS, Abbott Doral Investments S.L., Abbott Equity Holdings Unlimited, Abbott Equity Investments LLC, Abbott Established Products Holdings (Gibraltar) Limited, Abbott Finance Company SA, Abbott Financial Holdings SRL, Abbott France S.A.S., Abbott Fund Tanzania Limited, Abbott Gesellschaft m.b.H., Abbott GmbH & Co. KG, Abbott Health Products LLC, Abbott Healthcare (Puerto Rico) Ltd., Abbott Healthcare B.V., Abbott Healthcare Costa Rica S.A., Abbott Healthcare LLC, Abbott Healthcare Luxembourg S.à r.l., Abbott Healthcare Private Limited, Abbott Healthcare Products B.V., Abbott Healthcare Products Ltd, Abbott Holding (Gibraltar) Limited, Abbott Holding GmbH, Abbott Holding Subsidiary (Gibraltar) Limited, Abbott Holding Subsidiary (Gibraltar) Limited Luxembourg S.C.S., Abbott Holdings B.V., Abbott Holdings LLC, Abbott Holdings Limited, Abbott Holdings Poland Spółka z ograniczoną odpowiedzialnością, Abbott Hungary Korlátolt Felelősségű Társaság, Abbott Iberian Investments (2) Limited, Abbott Iberian Investments Limited, Abbott India Limited, Abbott Informatics Asia Pacific Limited, Abbott Informatics Canada Inc, Abbott Informatics Corporation, Abbott Informatics Europe Limited, Abbott Informatics France, Abbott Informatics Germany GmbH, Abbott Informatics Netherlands B.V., Abbott Informatics Singapore Pte. Limited, Abbott Informatics Spain S.A., Abbott Informatics Technologies Ltd, Abbott International Corporation, Abbott International Enterprises Ltd., Abbott International Holdings Limited, Abbott International LLC, Abbott International Luxembourg S.àr.l., Abbott Investments Luxembourg S.à r.l., Abbott Ireland, Abbott Ireland Financing Designated Activity Company, Abbott Ireland Limited, Abbott Japan Co. Ltd., Abbott Kazakhstan Limited Liability Partnership, Abbott Knoll Investments B.V., Abbott Korea Limited, Abbott Laboratories (Bangladesh) Limited, Abbott Laboratories (Chile) Holdco (Dos) SpA, Abbott Laboratories (Chile) Holdco SpA, Abbott Laboratories (Malaysia) Sdn. Bhd., Abbott Laboratories (Mozambique) Limitada, Abbott Laboratories (Pakistan) Limited, Abbott Laboratories (Philippines), Abbott Laboratories (Puerto Rico) Incorporated, Abbott Laboratories (Singapore) Private Limited, Abbott Laboratories A/S, Abbott Laboratories Argentina Sociedad Anónima, Abbott Laboratories B.V., Abbott Laboratories C.A., Abbott Laboratories Finance B.V., Abbott Laboratories GmbH, Abbott Laboratories Inc., Abbott Laboratories International LLC, Abbott Laboratories Ireland Limited, Abbott Laboratories Limited, Abbott Laboratories Limited - Laboratoires Abbott Limitée, Abbott Laboratories NZ Limited, Abbott Laboratories Pacific Ltd., Abbott Laboratories Poland Spółka z ograniczoną odpowiedzialnością, Abbott Laboratories Products B.V., Abbott Laboratories Residential Development Fund Inc., Abbott Laboratories S.A., Abbott Laboratories SA, Abbott Laboratories Services Corp., Abbott Laboratories Slovakia s.r.o., Abbott Laboratories South Africa (Pty) Ltd., Abbott Laboratories Trading (Shanghai) Co. Ltd., Abbott Laboratories Trustee Company Limited, Abbott Laboratories Uruguay S.A., Abbott Laboratories Vascular Enterprises, Abbott Laboratories d.o.o., Abbott Laboratories de Chile Limitada, Abbott Laboratories de Colombia S.A., Abbott Laboratories de México S.A. de C.V., Abbott Laboratories družba za farmacijo in diagnostiko d.o.o., Abbott Laboratories s.r.o., Abbott Laboratories(Hellas) Societe Anonyme, Abbott Laboratorios S.A., Abbott Laboratorios S.A., Abbott Laboratorios del Ecuador Cia. Ltda., Abbott Laboratuarlari Ithalat Ihracat ve Ticaret Ltd.Sti, Abbott Laboratórios Lda, Abbott Laboratórios do Brasil Ltda., Abbott Limited Egypt LLC, Abbott Logistics B.V., Abbott Management GmbH, Abbott Management LLC, Abbott Manufacturing Singapore Private Limited, Abbott Mature Products International Unlimited Company, Abbott Mature Products Management Limited, Abbott Medical (Hong Kong) Limited, Abbott Medical (Malaysia) Sdn. Bhd., Abbott Medical (Portugal) Distribuicao de Produtos Medicos Lda, Abbott Medical (Schweiz) AG, Abbott Medical (Shanghai) Co. Ltd., Abbott Medical (Singapore) Pte. Ltd., Abbott Medical (Thailand) Co. Ltd., Abbott Medical Australia Pty. Ltd., Abbott Medical Austria Ges.m.b.H., Abbott Medical Balkan d.o.o. Beograd (Novi Beograd), Abbott Medical Belgium, Abbott Medical Canada Inc./ Médicale Abbott Canada Inc., Abbott Medical Danmark A/S, Abbott Medical Devices Trading (Shanghai) Co. Ltd., Abbott Medical España S.A., Abbott Medical Estonia OÜ, Abbott Medical Finland Oy, Abbott Medical France SAS, Abbott Medical GmbH, Abbott Medical Hellas Limited Liability Trading Company, Abbott Medical Ireland Limited, Abbott Medical Italia S.p.A., Abbott Medical Japan Co. Ltd., Abbott Medical Korea Limited, Abbott Medical Korlátolt Felelősségű Társaság, Abbott Medical Laboratories LTD, Abbott Medical Nederland B.V., Abbott Medical New Zealand Limited, Abbott Medical Norway AS, Abbott Medical Overseas Cyprus Limited, Abbott Medical Sweden AB, Abbott Medical Taiwan Co., Abbott Medical U.K. Limited, Abbott Medical spółka z ograniczoną odpowiedzialnością, Abbott Middle East S.A.R.L., Abbott Molecular Inc., Abbott Morocco SARL, Abbott Nederland C.V., Abbott Nederland Luxembourg S.à r.l., Abbott Netherlands Investments B.V., Abbott Norge AS, Abbott Nutrition Limited, Abbott Nutrition Manufacturing Inc., Abbott Operations Singapore Pte. Ltd., Abbott Operations Uruguay S.R.L., Abbott Overseas Cyprus Limited, Abbott Overseas Luxembourg S.à r.l., Abbott Overseas S.A., Abbott Oy, Abbott Point of Care Canada Limited, Abbott Point of Care Inc., Abbott Poland Luxembourg S.à r.l., Abbott Procurement LLC, Abbott Products (Philippines) Inc., Abbott Products (Spain) S.L., Abbott Products Algerie EURL, Abbott Products B.V., Abbott Products Distribution SAS, Abbott Products Egypt LLC, Abbott Products Limited, Abbott Products Limited Liability Company, Abbott Products Luxembourg S.à r.l., Abbott Products Operations AG, Abbott Products Operations LLC, Abbott Products Romania S.R.L., Abbott Products Tunisie S.A.R.L., Abbott Products Unlimited Company, Abbott Resources Inc., Abbott Resources International Inc., Abbott S.r.l., Abbott Saudi Arabia Trading Company, Abbott Scandinavia Aktiebolag, Abbott Sociedad Anonima de Capital Variable, Abbott South Africa Luxembourg S.à r.l., Abbott Strategic Opportunities Limited, Abbott Trading Company Inc., Abbott Universal LLC, Abbott Vascular Devices (2) Limited, Abbott Vascular Devices Limited, Abbott Vascular Inc., Abbott Vascular Instruments Deutschland GmbH, Abbott Vascular International, Abbott Vascular Japan Co. Ltd, Abbott Vascular Limitada, Abbott Vascular Netherlands B.V., Abbott Vascular Solutions Inc., Abbott Ventures Inc., Abbott West Indies Limited, Abbott društvo sa ogranicenom odgovornošcu za trgovinu i usluge, Advanced Neuromodulation Systems Inc., Alere, Alere (Shanghai) Diagnostics Co. Ltd., Alere (Shanghai) Healthcare Management Co. Ltd., Alere (Shanghai) Medical Sales Co. Ltd., Alere (Shanghai) Technology Co. Ltd., Alere A/S, Alere AB, Alere AS, Alere AS Holdings Limited, Alere BBI Holdings Limited, Alere Bangladesh Limited, Alere China Co. Ltd., Alere Colombia S.A., Alere Connect LLC, Alere Connected Health Limited, Alere Connected Health Ltd., Alere Diagnostics GmbH, Alere DoA Holding GmbH, Alere GmbH, Alere GmbH (Austria), Alere GmbH (Germany), Alere HK Holdings Ltd., Alere Health B.V., Alere Health BVBA, Alere Health Corp., Alere Health Sdn Bhd, Alere Health Services B.V., Alere Healthcare (Pty) Limited, Alere Healthcare Connections Limited, Alere Healthcare Inc., Alere Healthcare Nigeria Limited, Alere Healthcare S.L., Alere Holdco Inc., Alere Holding GmbH, Alere Holdings Bermuda Limited, Alere Holdings Pty Limited, Alere Home Monitoring Inc., Alere Inc., Alere Informatics Inc., Alere International Holding Corp., Alere International Limited, Alere Lda, Alere Limited, Alere Limited (New Zealand), Alere Medical BVBA, Alere Medical Co. Ltd., Alere Medical Pakistan (Private) Limited, Alere Medical Private Limited, Alere North America LLC, Alere Oy Ab, Alere Philippines Inc., Alere Phoenix ACQ Inc., Alere Pte Ltd, Alere S.A., Alere S.r.l., Alere S/A, Alere SAS, Alere San Diego Inc., Alere Scarborough Inc., Alere Spain S.L., Alere Switzerland GmbH, Alere Technologies GmbH, Alere Technologies Holdings Limited, Alere Technologies Limited, Alere Toxicology AB, Alere Toxicology Inc., Alere Toxicology S.r.l., Alere Toxicology Services Inc., Alere Toxicology plc, Alere UK Holdings Limited, Alere UK Subco Limited, Alere ULC, Alere US Holdings LLC, Alere s.r.o., Alisoc Investment & Co, Amedica Biotech Inc., Ameditech Inc., American Generics S.A.S., American Medical Supplies Inc., American Pharmacist Inc., Antares S.A., Apica Cardiovascular Limited, Aquagestion Capacitación S.A., Aquagestion S.A., Arriva Medical LLC, Arriva Medical Philippines Inc., Arvis Investments Limited, Atlas Farmacéutica S.A., Avee Laboratories Inc., Axis-Shield AD III AS, Axis-Shield AD IV AS, Axis-Shield AS, Axis-Shield Diagnostics Limited, Axis-Shield Ltd., BBI Animal Health Limited, BBI Diagnostics Group 2 Public Limited Company, Banco de Vida S.A., Bioabsorbable Vascular Solutions Inc., Bioalgae S.A., Biohealth LLC, Biosite Incorporated, Bosque Bonito S.A., Branan Medical Corporation, Brandex Europe C.V., British Colloids Limited, CFR Chile S.A., CFR Interamericas EL Salvador Sociedad Anónima de Capital Variable, CFR Interamericas Nicaragua Sociedad Anónima, CFR Interamericas Panamá S.A., CFR Pharmaceuticals, California Property Holdings III LLC, CardioMEMS LLC, Caripharm Inc., Cephea Valve Technologies, Cephea Valve Technologies Inc., Colibri Medical Aktiebolag, Comercializadora y Distribuidora CFR Interamericas Honduras S.A., Concateno South Limited, Concateno UK Limited, Consorcio Tecnológico en Biomedicina Clinico-Molecular S.A., Continuum Services LLC, Cozart Limited, Dextech S.A., Diagnostik Nord GmbH, Distribuciones Uquifa S.A.S., Domesco Medical Import-Export Joint-Stock Corporation, Duphar International Research B.V., Endocardial Solutions, Epocal (US) Inc, Esprit de Vie S.A., European Chemicals & Co, European Drug Testing Service EDTS AB, European Services S.A., Evalve Inc., Evalve International Inc., FARMINDUSTRIA S.A., Fada Pharma Paraguay Sociedad Anonima, Fadapharma del Ecuador S.A., Farmaceutica Mont Blanc S.L., Farmacologia Em Aquicultura Veterinária Ltda., Farmacologia en Aquacultura Veterinaria FAV Ecuador S.A., Farmacología en Aquacultura Veterinaria FAV S.A., Fernwood Investment S.A., First Check Diagnostics LLC, Focus Pharmaceutical S.A.S., Forensics Limited, Forestcreek Overseas S.A., Fournier Pharma Corp., Fournier Pharma GmbH, Fournier Pharmaceuticals Limited, Framed B.V., Gabmed GmbH, Garden Hills LLC, Global Analytical Development LLC, Globapharm & CO LP, Glomed Pharmaceutical Company Limited, Golnorth Investments S.A., Gynocare Limited, Gynopharm Sociedad Anonima, Gynopharm de Centroamérica S.A., Gynopharm de Venezuela C.A., Hi-Tronics Designs Inc., IDEV Technologies Inc., IG Innovations Limited, IMTC Finance B.V., IMTC Holdings B.V., IMTC Technologies Inc., Ibis Biosciences LLC, Igloo Zone Chile S.A., Igloo Zone S.L., Inmobiliaria Naknek S.A.C., Innovacon Inc., Instant Tech Subsidiary Acquisition Inc., Instant Technologies Inc., Instituto de Criopreservación de Chile S.A., Integrated Vascular Systems Inc., Inverness Canadian Acquisition Corporation, Inverness Medical (Beijing) Co. Ltd., Inverness Medical Innovations Australia Pty Ltd., Inverness Medical Innovations Hong Kong Limited, Inverness Medical Innovations SK LLC, Inverness Medical Investments LLC, Inverness Medical LLC, Inverness Medical Shimla Private Limited, Inversiones K2 SpA, Inversiones Komodo S.R.L., Ionian Technologies LLC, Irvine Biomedical Inc., Kalila Medical, Kangshenyunga S.A., Knoll UK Investments Unlimited, LLC “VeroInPharm”, Laboratoires Fournier S.A.S., Laboratorio Franco Colombiano Lafrancol S.A.S., Laboratorio Franco Colombiano del Ecuador S.A., Laboratorio Internacional Argentino S.A., Laboratorio Synthesis S.A.S., Laboratorios Lafi Limitada, Laboratorios Naturmedik S.A.S., Laboratorios Pauly Pharmaceutical S.A.S., Laboratorios Recalcine S.A., Laboratorios Transpharm S.A., Laboratory Specialists of America Inc., Lafrancol Dominicana S.A.S., Lafrancol Guatemala S.A. Sociedad Anónima, Lafrancol Internacional S.A.S, Lafrancol Perú S.R.L, Lake Forest Investments LLC, Lightlab Imaging Inc., Limited Liability Company Abbott Laboratories, Limited Liability Company “Abbott Ukraine”, Limited Liability Company “VEROPHARM”, Lung Fung Hong (China) Limited, Mansbridge Pharmaceuticals Limited, MediGuide LLC, MediGuide Ltd., Medscreen Holdings Limited, Metropolitana Farmacéutica S.A., Midwest Properties LLC, Murex Argentina S.A., Murex Biotech Limited, Murex Biotech South Africa, Murex Diagnostics Inc., Murex Diagnostics International Inc., Natural Supplement Association LLC, Negocios Denia Sociedad Anónima, Neosalud S.A.C., Nether Pharma N.P. C.V., NeuroTherm LLC, Normann Pharma-Handels GmbH, North Shore Properties Inc., Novamedi S.A., Novasalud.com S.A., Nutravida S.A., OJSC “Voronezhkhimpharm”, Omnilab Iberia Sociedad Limitada, OptiMedica, Orgenics France SAS, Orgenics International Holdings B.V., Orgenics Ltd., PBM-Selfcare LLC, PDD II LLC, PDD LLC, PT Alere Health, PT. Abbott Indonesia, PT. Abbott Products Indonesia, Pacesetter Inc., Pantech (RF) (PTY) LTD, Pembrooke Occupational Health Inc., Penagos S.A., Pharma International Sociedad Anonima, Pharmaceutical Technologies (Pharmatech) S.A., Pharmatech Boliviana S.A., Polygon Labs S.A., Quality Assured Services Inc., RF Medical Holdings LLC, RTL Holdings Inc., Ramses Business Corp., Recben Xenerics Farmaceutica Limitada, Redwood Toxicology Laboratory Inc., Rich Horizons International Limited, SC “VEROPHARM”, SJ Medical Mexico S de R.L. de C.V., SJM International Inc., SJM Thunder Holding Company, SPDH Inc., Saboya Enterprises Corporation, Salviac Limited, Scanax AS, Sealing Solutions Inc., Selfcare Technology Inc., Shandong Abbott Dairy Product Co. Ltd., Shanghai Abbott Medical Devices Science and Technology Co. Ltd., Shanghai Abbott Pharmaceutical Co. Ltd., Shanghai Si Fa Pharmaceutical Company Limited, Sinensix & Co., Spinal Modulation LLC, St. Jude Medical, St. Jude Medical AB, St. Jude Medical ATG Inc., St. Jude Medical Argentina S.A., St. Jude Medical Asia Pacific Holdings GK, St. Jude Medical Atrial Fibrillation Division Inc., St. Jude Medical Brasil Ltda., St. Jude Medical Business Services Inc., St. Jude Medical Cardiology Division Inc., St. Jude Medical Colombia Ltda., St. Jude Medical Coordination Center, St. Jude Medical Costa Rica Limitada, St. Jude Medical Europe Inc., St. Jude Medical Export Ges.m.b.H., St. Jude Medical GVA Sàrl, St. Jude Medical Holdings B.V., St. Jude Medical India Private Limited, St. Jude Medical International Holding, St. Jude Medical LLC, St. Jude Medical Luxembourg, St. Jude Medical Luxembourg Holdings II, St. Jude Medical Luxembourg Holdings NT, St. Jude Medical Luxembourg Holdings SMI S.à r.l., St. Jude Medical Luxembourg Holdings TC S.à r.l., St. Jude Medical Mexico Business Services S. de R.L. de C.V., St. Jude Medical Middle East DMCC, St. Jude Medical Operations (Malaysia) Sdn. Bhd., St. Jude Medical Puerto Rico LLC, St. Jude Medical S.C. Inc., St. Jude Medical Systems AB, St. Jude Medical Turkey Medikal Ürünler Ticaret Limited Sirketi, Standard Diagnostics Inc., Standing Stone LLC, Swan-Myers Incorporated, TC1 LLC, Tendyne Holdings Inc., Tendyne Medical Inc., Thoratec Delaware LLC, Thoratec Europe Limited, Thoratec LLC, Thoratec Switzerland GmbH, Tobal Products Incorporated, Topera GmbH in Liquidation, Topera Inc., Tremora S.A., Tuenir S.A., TwistDx, UAB “Abbott Laboratories”, UAB “Abbott Medical Lithuania”, Union-Madison Realty Company Inc., Unipath Limited (dba Alere International/aka Cranfield), Unipath Management Limited, Unipath Pension Trustee Limited, Veropharm, Veropharm Limited Liability Partnership, Vida Cell Inversiones S.A., Vida Cell S.A., Vivalsol, W&R Pharma Handels GmbH, Western Pharmaceuticals S.A., X Technologies Inc., Yissum Holding Limited, ZonePerfect Nutrition Company, eScreen Canada ULC, eScreen Inc., Товариство з обмеженою відповідальністю «Верофарм» (ТОВ «Верофарм»), and “Abbott Laboratories Baltics”.
Read More
This page (NYSE:ABT) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners